These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MYC, c-Myc, 4609, ENSG00000136997
1798 results:

  • 1. [Mechanism of Modified Huoluo Xiaoling Pills against colorectal cancer based on network pharmacology, molecular docking, and experimental validation].
    Jiang W; Zhao QP; Huang L; Jiang JW; Li ML; Chen XC; Xu Y; Wang GJ; Deng L; Zhang LC; Li ZM
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(13):3657-3667. PubMed ID: 39041138
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]    [Full Text] [Related]  

  • 3. The ubiquitin-like protein UBTD1 promotes colorectal cancer progression by stabilizing c-myc to upregulate glycolysis.
    Zhao L; Yu N; Zhai Y; Yang Y; Wang Y; Yang Y; Gong Z; Zhang Y; Zhang X; Guo W
    Cell Death Dis; 2024 Jul; 15(7):502. PubMed ID: 39003255
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Dual inhibition of SUMOylation and MEK conquers myc-expressing KRAS-mutant cancers by accumulating DNA damage.
    Kotani H; Oshima H; Boucher JC; Yamano T; Sakaguchi H; Sato S; Fukuda K; Nishiyama A; Yamashita K; Ohtsubo K; Takeuchi S; Nishiuchi T; Oshima M; Davila ML; Yano S
    J Biomed Sci; 2024 Jul; 31(1):68. PubMed ID: 38992694
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Manuka honey's anti-metastatic impact on colon cancer stem-like cells: unveiling its effects on epithelial-mesenchymal transition, angiogenesis and telomere length.
    Cianciosi D; Forbes-Hernandez T; Armas Diaz Y; Elexpuru-Zabaleta M; Quiles JL; Battino M; Giampieri F
    Food Funct; 2024 Jul; 15(13):7200-7213. PubMed ID: 38896046
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. SIRT6 Inhibits Anoikis of colorectal cancer Cells by Down-Regulating NDRG1.
    Li F; Yu W; Zhou X; Hou J; Gao Y; Zhang J; Gao X
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891773
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Four-Gene Panel in Rectal Swab Samples as a Biomarker for colorectal cancer Screening.
    Ng L; Wong SK; Li HS; Sin RW; Man JH; Lo OS; Pang RW; Foo DC; Law WL
    Cells; 2024 May; 13(11):. PubMed ID: 38891062
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer.
    Mahajan M; Sarkar A; Mondal S
    Cancer Med; 2024 Jun; 13(11):e7391. PubMed ID: 38872418
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
    Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
    Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeting AURKA to induce synthetic lethality in CREBBP-deficient B-cell malignancies via attenuation of myc expression.
    Sun Y; Chen J; Hong JH; Xiao R; Teng Y; Wang P; Deng P; Yu Z; Chan JY; Chai KXY; Gao J; Wang Y; Pan L; Liu L; Liu S; Teh BT; Yu Q; Lim ST; Li W; Xu B; Ong CK; Tan J
    Oncogene; 2024 Jul; 43(28):2172-2183. PubMed ID: 38783101
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Perfluorooctanesulfonic acid exposure leads to downregulation of 3-hydroxy-3-methylglutaryl-CoA synthase 2 expression and upregulation of markers associated with intestinal carcinogenesis in mouse intestinal tissues.
    Tessmann JW; Deng P; Durham J; Li C; Banerjee M; Wang Q; Goettl RA; He D; Wang C; Lee EY; Evers BM; Hennig B; Zaytseva YY
    Chemosphere; 2024 Jul; 359():142332. PubMed ID: 38754493
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis.
    Lu Y; Cui A; Zhang X
    Gut Microbes; 2024; 16(1):2348441. PubMed ID: 38706224
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. myc and NCAPG2 as molecular targets of colorectal cancer and gastric cancer in nursing.
    Mi X; Shan H; Kang C; Zhang J; Hou S; Gao Y; Hao L; Gao X; Gao Q; Chi X; Zhang Q
    Medicine (Baltimore); 2024 May; 103(18):e38029. PubMed ID: 38701261
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of genes related to ribosomal proteins in colorectal cancer: exploring their potential as biomarkers, prognostic indicators, and therapeutic targets.
    Salehinia N; Mohammad Al-Mosawi AK; Al-Moussawi DK; Sadeghi ES; Zamani A; Mahdevar M
    Mol Biol Rep; 2024 Apr; 51(1):576. PubMed ID: 38664314
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation.
    Perri G; Vilas Boas VG; Nogueira MRS; Mello Júnior EJF; Coelho AL; Posadas EM; Hogaboam C; Cavassani KA; Campanelli AP
    Cancer Immunol Immunother; 2024 Apr; 73(6):110. PubMed ID: 38662248
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mining and exploration of rehabilitation nursing targets for colorectal cancer.
    Li R; He J; Ni Z; Zhang J; Chi X; Kang C; Li Z; Li X
    Aging (Albany NY); 2024 Apr; 16(8):7022-7042. PubMed ID: 38637125
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. STK16 promoted colorectal cancer progress in a c-myc signaling-dependent manner.
    Peng L; Guangshi L; Wusman LB; Tao L
    Mol Med; 2024 Apr; 30(1):50. PubMed ID: 38622518
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. BET inhibition induces synthetic lethality in PTEN deficient colorectal cancers via dual action on p21
    Ren G; Chen J; Pu Y; Yang EJ; Tao S; Mou PK; Chen LJ; Zhu W; Chan KL; Luo G; Deng C; Shim JS
    Int J Biol Sci; 2024; 20(6):1978-1991. PubMed ID: 38617536
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome.
    Wu S; Dai X; Xia Y; Zhao Q; Zhao H; Shi Z; Yin X; Liu X; Zhang A; Yao Z; Zhang H; Li Q; Thorne RF; Zhang S; Sheng W; Hu W; Gu H
    Cell Rep; 2024 Apr; 43(4):114111. PubMed ID: 38615319
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 90.